首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   403篇
  免费   23篇
  国内免费   1篇
儿科学   13篇
妇产科学   8篇
基础医学   36篇
口腔科学   5篇
临床医学   52篇
内科学   46篇
皮肤病学   1篇
神经病学   66篇
特种医学   11篇
外科学   37篇
综合类   6篇
预防医学   81篇
眼科学   4篇
药学   26篇
肿瘤学   35篇
  2023年   3篇
  2022年   5篇
  2021年   12篇
  2020年   6篇
  2019年   9篇
  2018年   15篇
  2017年   11篇
  2016年   10篇
  2015年   14篇
  2014年   15篇
  2013年   28篇
  2012年   41篇
  2011年   37篇
  2010年   23篇
  2009年   18篇
  2008年   24篇
  2007年   24篇
  2006年   17篇
  2005年   23篇
  2004年   21篇
  2003年   16篇
  2002年   7篇
  2001年   8篇
  2000年   1篇
  1999年   2篇
  1998年   3篇
  1997年   4篇
  1996年   2篇
  1995年   2篇
  1994年   2篇
  1992年   8篇
  1991年   2篇
  1990年   1篇
  1989年   2篇
  1988年   3篇
  1982年   2篇
  1979年   2篇
  1978年   2篇
  1973年   1篇
  1972年   1篇
排序方式: 共有427条查询结果,搜索用时 31 毫秒
1.
2.
Asymmetry in brain modulation of the immune system has been previously described. In mice, paw preference has been shown to be associated with immune reactivity but the mechanisms involved in such an association are not yet known. The autonomic nervous system and the neuroendocrine system are considered as major candidates for neural influences on the immune system. In the present study, the activity of the hypothalamic-pituitary-adrenal (HPA) axis of adult female mice selected for paw preference (left-handers vs. right-handers) was assessed by measuring both adrenocorticotropic hormone (ACTH) and corticosterone plasma levels, as well as the in vitro responses of hypothalamus and adrenocortical cells to various hormone releasing stimuli. The results reported here showed no difference in the activity of the HPA axis between left- and right-handed mice, suggesting that this neuroendocrine axis is not implicated in the association between functional brain asymmetry and immune reactivity. However, our results do not exclude the possibility that the HPA axis could play a role in such an association under other circumstances, such as during development or stressful situations.  相似文献   
3.
PurposeTo report outcomes of Debridement, Antibiotic therapy and Implant Retention (DAIR) for periprosthetic knee joint infections (PJI) in the Indian population and to study factors influencing outcomes.MethodsThis was a Retrospective study of 80 cases of acute PJI after total knee arthroplasty who were treated by DAIR, within 2 weeks of onset of infection. A standardised institutional management protocol was applied to all cases. Patients were followed up for a minimum 1 year. Outcomes of DAIR were classified as successful or unsuccessful based on resolution or persistence of infection, and subsequent requirement of revision surgery. Influence of factors, like comorbidities, culture status and microbiological characteristics of causative organism, on outcomes was assessed.ResultsOverall 55 patients (68.75%) had successful eradication of infection after DAIR. 27 (33.7%) patients were culture negative and 53 (66.2%) patients grew organisms on culture. There was no statistically significant difference in outcomes (p = 0.082) between culture-positive cases (69.8% success rate) and (66.7% success rate) in culture negative cases. Furthermore, no difference in outcomes was observed in culture-positive patients between those who grew Gram-positive organisms versus Gram-negative organisms (p = 0.398) Similarly, patient comorbidities did not significantly alter the outcomes after DAIR (p = 0.732).ConclusionOur study demonstrates that early DAIR within 2 weeks of onset of infection using a standard protocol during surgery and postoperatively can result in good outcomes. Patient comorbidities, culture status (positive versus negative), Gram staining characteristics of organisms and the identity of pathogenic bacteria did not influence outcomes of DAIR for acute PJI.  相似文献   
4.
A simple, specific, precise, sensitive and rapid reverse phase-HPLC method was developed for determination of ketorolac enantiomers, a potent nonnarcotic analgesic in pharmaceutical formulations. The method was developed on a chiral AGP column. Mobile phase was 0.1 M sodium phosphate buffer (pH 4.5): Isopropanol (98:2, v/v), at a flow rate of 1 mL/min with run time of 15 min. Ultraviolet detection was made at 322 nm. The linearity range was 0.02–10 μg/mL for each of the enantiomers. The mobile phase composition was systematically studied to find the optimum chromatographic conditions. Validation of the method under the conditions selected showed that it was selective and precise and that the detector response was linear function of ketorolac.  相似文献   
5.
6.
7.
经食管心房调搏对阵发性室上性心动过速的诊断价值   总被引:4,自引:0,他引:4  
目的 探讨经食管心房调搏对阵发性室上性心动过速的分型及定位诊断价值。方法 回顾性分析食管心房调搏对193例阵发性室上性心动过速分型及定位诊断结果,并与心内电生理检查诊断结果比较。结果 经食管心房调搏对慢-快型AVNRT及顺向性AVRT的诊断敏感性、特异性、准确性均较高,对少见型AVNRT的诊断敏感性低(25%)。结论 阵发性室上性心动过速发作时食管与体表心电图P^-波起始与极性是诊断阵发性室上性心动过速的关键。经食管心房调搏对心动过速旁道定位误诊原因主要是心动过速时体表心电图P^-波往往与T波融合,导致V1、I导联P^-波极性及V1导联P^-波起始部形态改变。  相似文献   
8.
9.
10.
Surprisingly, survival from a diagnosis of lung cancer has been found to be longer for those who experienced a previous cancer than for those with no previous cancer. A possible explanation is lead‐time bias, which, by advancing the time of diagnosis, apparently extends survival among those with a previous cancer even when they enjoy no real clinical advantage. We propose a discrete parametric model to jointly describe survival in a no‐previous‐cancer group (where, by definition, lead‐time bias cannot exist) and in a previous‐cancer group (where lead‐time bias is possible). We model the lead time with a negative binomial distribution and the post–lead‐time survival with a linear spline on the logit hazard scale, which allows for survival to differ between groups even in the absence of bias; we denote our model Logit‐Spline/Negative Binomial. We fit Logit‐Spline/Negative Binomial to a propensity‐score matched subset of the Surveillance, Epidemiology, and End Results–Medicare linked data set, conducting sensitivity analyses to assess the effects of key assumptions. With lung cancer–specific death as the end point, the estimated mean lead time is roughly 11 months for stage I&II patients; with overall survival, it is roughly 3.4 months in stage I&II. For patients with higher‐stage lung cancers, the mean lead time is 1 month or less for both outcomes. Accounting for lead‐time bias reduces the survival advantage of the previous‐cancer group when one exists, but it does not nullify it in all cases.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号